US Stock MarketDetailed Quotes

RXRX Recursion Pharmaceuticals

Watchlist
  • 5.750
  • -0.290-4.80%
Close Nov 21 16:00 ET
  • 5.770
  • +0.020+0.34%
Post 17:30 ET
1.65BMarket Cap-3733P/E (TTM)

Recursion Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
18.78%-59.23M
-21.87%-82.22M
-39.53%-102.3M
-244.55%-287.78M
-65.54%-74.08M
-33.70%-72.92M
-9.48%-67.47M
-194.74%-73.32M
47.34%-83.52M
26.83%-44.75M
Net income from continuing operations
-3.04%-95.84M
-27.13%-97.54M
-39.87%-91.37M
-36.99%-328.07M
-61.75%-93M
-53.89%-93.02M
-17.03%-76.73M
-16.70%-65.33M
-28.42%-239.48M
11.46%-57.49M
Depreciation and amortization
-5.01%7.2M
61.79%8.97M
97.88%7.38M
107.57%24.4M
135.00%7.55M
153.53%7.58M
98.96%5.54M
34.73%3.73M
39.87%11.76M
43.74%3.21M
Other non cash items
4,900.00%8.5M
-95.41%93K
-29.29%1.91M
33.76%11.45M
168.88%6.55M
-90.41%170K
-8.20%2.03M
26.12%2.7M
108.93%8.56M
110.54%2.44M
Change In working capital
159.75%2.67M
-1.41%-10.26M
-49.36%-36.45M
-147.90%-50.26M
-1,775.21%-11.27M
42.54%-4.46M
-6.12%-10.12M
-119.87%-24.4M
34,387.91%104.92M
84.82%-601K
-Change in receivables
-362.56%-939K
190.42%736K
-228.08%-1.04M
-387,700.00%-7.76M
-215.25%-6.42M
-105.37%-203K
54.78%-814K
95.80%-317K
99.96%-2K
306.72%5.57M
-Change in payables and accrued expense
-47.78%4.39M
-10.45%4.26M
-88.89%-17.96M
392.53%8.44M
-50.65%4.78M
131.91%8.41M
207.30%4.76M
27.67%-9.51M
-88.63%1.71M
442.35%9.69M
-Change in other current liabilities
-87.52%-4.7M
12.47%-2.62M
-55.24%-3.79M
-38.71%-9.86M
12.41%-1.91M
-18.58%-2.51M
-93.79%-3M
-93.20%-2.44M
---7.11M
---2.18M
-Change in other working capital
138.55%3.92M
-14.19%-12.64M
-12.54%-13.66M
-137.23%-41.08M
43.58%-7.72M
22.16%-10.16M
-43.01%-11.07M
-108.38%-12.13M
1,203.20%110.32M
-447.00%-13.68M
Cash from discontinued investing activities
Operating cash flow
18.78%-59.23M
-21.87%-82.22M
-39.53%-102.3M
-244.55%-287.78M
-65.54%-74.08M
-33.70%-72.92M
-9.48%-67.47M
-194.74%-73.32M
47.34%-83.52M
26.83%-44.75M
Investing cash flow
Cash flow from continuing investing activities
-1,214.70%-4.56M
-103.70%-4.18M
-24.59%-6.65M
-105.29%-10.23M
68.82%-2.49M
-100.65%-347K
-141.56%-2.05M
-103.73%-5.34M
171.11%193.25M
84.73%-7.98M
Net PPE purchase and sale
-512.35%-4.56M
70.21%-1.18M
-28.56%-6.65M
67.74%-11.96M
74.09%-2.07M
90.98%-745K
75.92%-3.97M
-19.18%-5.18M
6.88%-37.06M
-78.74%-7.98M
Net intangibles purchase and sale
--0
---3M
--0
-99.00%-597K
---350K
72.67%-82K
--0
---165K
---300K
--0
Net business purchase and sale
--0
----
----
--1.84M
---71K
--0
----
----
--0
--0
Net investment purchase and sale
----
----
----
-99.79%480K
--0
----
----
----
199.42%230.61M
--0
Cash from discontinued investing activities
Investing cash flow
-1,214.70%-4.56M
-103.70%-4.18M
-24.59%-6.65M
-105.29%-10.23M
68.82%-2.49M
-100.65%-347K
-141.56%-2.05M
-103.73%-5.34M
171.11%193.25M
84.73%-7.98M
Financing cash flow
Cash flow from continuing financing activities
-69.38%16.46M
6,848.03%263.12M
623.05%13.9M
-9.21%140.13M
-45.23%80.66M
2,200.60%53.77M
41.94%3.79M
-7.77%1.92M
-66.34%154.35M
3,779.24%147.26M
Net issuance payments of debt
-9,429.17%-2.29M
-8.33%-26K
-8.33%-26K
-751.11%-766K
-2,917.39%-694K
-4.35%-24K
-9.09%-24K
-9.09%-24K
99.30%-90K
-9.52%-23K
Net common stock issuance
-66.06%16.97M
--261.55M
--10.87M
-10.87%128.09M
-45.66%78.09M
--50M
--0
--0
-68.95%143.71M
--143.71M
Proceeds from stock option exercised by employees
-53.00%1.78M
-57.96%1.6M
56.73%3.05M
19.41%12.81M
-8.63%3.26M
60.55%3.79M
41.67%3.81M
-7.60%1.95M
27.11%10.72M
-6.52%3.57M
Cash from discontinued financing activities
Financing cash flow
-69.38%16.46M
6,848.03%263.12M
623.05%13.9M
-9.21%140.13M
-45.23%80.66M
2,200.60%53.77M
41.94%3.79M
-7.77%1.92M
-66.34%154.35M
3,779.24%147.26M
Net cash flow
Beginning cash position
15.82%482.75M
-36.53%306.15M
-28.20%401.43M
89.31%559.11M
-14.56%397.21M
-10.19%416.82M
-6.90%482.38M
89.31%559.11M
10.55%295.35M
14.80%464.89M
Current changes in cash
-142.67%-47.33M
368.85%176.72M
-23.88%-95.06M
-159.79%-157.88M
-95.67%4.09M
-2,600.26%-19.5M
-21.69%-65.73M
-134.44%-76.73M
837.02%264.07M
186.25%94.53M
Effect of exchange rate changes
450.43%403K
-165.19%-118K
-10,850.00%-219K
161.24%188K
140.39%124K
---115K
--181K
---2K
---307K
---307K
End cash Position
9.72%435.83M
15.82%482.75M
-36.53%306.15M
-28.20%401.43M
-28.20%401.43M
-14.56%397.21M
-10.19%416.82M
-6.90%482.38M
89.31%559.11M
89.31%559.11M
Free cash flow
13.51%-63.79M
-20.95%-86.4M
-38.52%-108.95M
-148.45%-300.33M
-45.08%-76.49M
-16.87%-73.75M
8.53%-71.44M
-207.68%-78.66M
39.07%-120.88M
19.65%-52.73M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 18.78%-59.23M-21.87%-82.22M-39.53%-102.3M-244.55%-287.78M-65.54%-74.08M-33.70%-72.92M-9.48%-67.47M-194.74%-73.32M47.34%-83.52M26.83%-44.75M
Net income from continuing operations -3.04%-95.84M-27.13%-97.54M-39.87%-91.37M-36.99%-328.07M-61.75%-93M-53.89%-93.02M-17.03%-76.73M-16.70%-65.33M-28.42%-239.48M11.46%-57.49M
Depreciation and amortization -5.01%7.2M61.79%8.97M97.88%7.38M107.57%24.4M135.00%7.55M153.53%7.58M98.96%5.54M34.73%3.73M39.87%11.76M43.74%3.21M
Other non cash items 4,900.00%8.5M-95.41%93K-29.29%1.91M33.76%11.45M168.88%6.55M-90.41%170K-8.20%2.03M26.12%2.7M108.93%8.56M110.54%2.44M
Change In working capital 159.75%2.67M-1.41%-10.26M-49.36%-36.45M-147.90%-50.26M-1,775.21%-11.27M42.54%-4.46M-6.12%-10.12M-119.87%-24.4M34,387.91%104.92M84.82%-601K
-Change in receivables -362.56%-939K190.42%736K-228.08%-1.04M-387,700.00%-7.76M-215.25%-6.42M-105.37%-203K54.78%-814K95.80%-317K99.96%-2K306.72%5.57M
-Change in payables and accrued expense -47.78%4.39M-10.45%4.26M-88.89%-17.96M392.53%8.44M-50.65%4.78M131.91%8.41M207.30%4.76M27.67%-9.51M-88.63%1.71M442.35%9.69M
-Change in other current liabilities -87.52%-4.7M12.47%-2.62M-55.24%-3.79M-38.71%-9.86M12.41%-1.91M-18.58%-2.51M-93.79%-3M-93.20%-2.44M---7.11M---2.18M
-Change in other working capital 138.55%3.92M-14.19%-12.64M-12.54%-13.66M-137.23%-41.08M43.58%-7.72M22.16%-10.16M-43.01%-11.07M-108.38%-12.13M1,203.20%110.32M-447.00%-13.68M
Cash from discontinued investing activities
Operating cash flow 18.78%-59.23M-21.87%-82.22M-39.53%-102.3M-244.55%-287.78M-65.54%-74.08M-33.70%-72.92M-9.48%-67.47M-194.74%-73.32M47.34%-83.52M26.83%-44.75M
Investing cash flow
Cash flow from continuing investing activities -1,214.70%-4.56M-103.70%-4.18M-24.59%-6.65M-105.29%-10.23M68.82%-2.49M-100.65%-347K-141.56%-2.05M-103.73%-5.34M171.11%193.25M84.73%-7.98M
Net PPE purchase and sale -512.35%-4.56M70.21%-1.18M-28.56%-6.65M67.74%-11.96M74.09%-2.07M90.98%-745K75.92%-3.97M-19.18%-5.18M6.88%-37.06M-78.74%-7.98M
Net intangibles purchase and sale --0---3M--0-99.00%-597K---350K72.67%-82K--0---165K---300K--0
Net business purchase and sale --0----------1.84M---71K--0----------0--0
Net investment purchase and sale -------------99.79%480K--0------------199.42%230.61M--0
Cash from discontinued investing activities
Investing cash flow -1,214.70%-4.56M-103.70%-4.18M-24.59%-6.65M-105.29%-10.23M68.82%-2.49M-100.65%-347K-141.56%-2.05M-103.73%-5.34M171.11%193.25M84.73%-7.98M
Financing cash flow
Cash flow from continuing financing activities -69.38%16.46M6,848.03%263.12M623.05%13.9M-9.21%140.13M-45.23%80.66M2,200.60%53.77M41.94%3.79M-7.77%1.92M-66.34%154.35M3,779.24%147.26M
Net issuance payments of debt -9,429.17%-2.29M-8.33%-26K-8.33%-26K-751.11%-766K-2,917.39%-694K-4.35%-24K-9.09%-24K-9.09%-24K99.30%-90K-9.52%-23K
Net common stock issuance -66.06%16.97M--261.55M--10.87M-10.87%128.09M-45.66%78.09M--50M--0--0-68.95%143.71M--143.71M
Proceeds from stock option exercised by employees -53.00%1.78M-57.96%1.6M56.73%3.05M19.41%12.81M-8.63%3.26M60.55%3.79M41.67%3.81M-7.60%1.95M27.11%10.72M-6.52%3.57M
Cash from discontinued financing activities
Financing cash flow -69.38%16.46M6,848.03%263.12M623.05%13.9M-9.21%140.13M-45.23%80.66M2,200.60%53.77M41.94%3.79M-7.77%1.92M-66.34%154.35M3,779.24%147.26M
Net cash flow
Beginning cash position 15.82%482.75M-36.53%306.15M-28.20%401.43M89.31%559.11M-14.56%397.21M-10.19%416.82M-6.90%482.38M89.31%559.11M10.55%295.35M14.80%464.89M
Current changes in cash -142.67%-47.33M368.85%176.72M-23.88%-95.06M-159.79%-157.88M-95.67%4.09M-2,600.26%-19.5M-21.69%-65.73M-134.44%-76.73M837.02%264.07M186.25%94.53M
Effect of exchange rate changes 450.43%403K-165.19%-118K-10,850.00%-219K161.24%188K140.39%124K---115K--181K---2K---307K---307K
End cash Position 9.72%435.83M15.82%482.75M-36.53%306.15M-28.20%401.43M-28.20%401.43M-14.56%397.21M-10.19%416.82M-6.90%482.38M89.31%559.11M89.31%559.11M
Free cash flow 13.51%-63.79M-20.95%-86.4M-38.52%-108.95M-148.45%-300.33M-45.08%-76.49M-16.87%-73.75M8.53%-71.44M-207.68%-78.66M39.07%-120.88M19.65%-52.73M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme NVIDIA Portfolio
NVIDIA Portfolio
Intraday-0.32%